| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/11/2002 | WO2002028370A1 Biodegradable microparticles for controlled release administration, with purified amylopectin-based starch of reduced molecular weight |
| 04/11/2002 | WO2002028368A1 New combination for the treatment of asthma |
| 04/11/2002 | WO2002028367A1 Method of coating fine particle with lipid film |
| 04/11/2002 | WO2002028366A2 Devices and methods for management of inflammation |
| 04/11/2002 | WO2002028365A2 Stabilization of solid drug formulations |
| 04/11/2002 | WO2002028364A2 Stabilization of solid thyroid drug formulations |
| 04/11/2002 | WO2002028363A1 Eye instillation with decongestant effect |
| 04/11/2002 | WO2002028362A2 Vaccine composition and stabilisation method |
| 04/11/2002 | WO2002028181A1 Sustained release pharmaceutical compositions containing metformin and method of its production |
| 04/11/2002 | WO2002028180A2 Antimicrobial compositions formulated for use in cold temperature conditions and methods of use thereof |
| 04/11/2002 | WO2002007715A3 A method for treating celiac disease |
| 04/11/2002 | WO2002007674A3 Enhancing compound penetration into hair follicles |
| 04/11/2002 | WO2002000206A3 Tamper-evident capsule system |
| 04/11/2002 | WO2001098328A3 Glycopeptide phosphonate derivatives |
| 04/11/2002 | WO2001097635A3 Microcapsules containing arginine and the different uses thereof |
| 04/11/2002 | WO2001085128A3 Skin protectant spray compositions |
| 04/11/2002 | WO2001082868A3 A medicinal aerosol formulation |
| 04/11/2002 | WO2001080920A3 Antimicrobial bioabsorbable materials |
| 04/11/2002 | WO2001080827A3 Salicylic acid acne spray formulations and methods for treating acne with same |
| 04/11/2002 | WO2001078680A3 Pharmaceutical compositions comprising fluvastatin |
| 04/11/2002 | WO2001072278A3 Method for administering insulin to the buccal region |
| 04/11/2002 | WO2001066085A3 Micellar pharmaceutical compositions for buccal and pulmonary application |
| 04/11/2002 | WO2001054647A3 Pharmaceutical composition comprising carriers for products based on vitamin-e, papain and hyaluronidase |
| 04/11/2002 | WO2001034121A3 Multi-layer preparation in film form, consisting of hydrophilic polymers, for the rapid release of active ingredients |
| 04/11/2002 | WO2001028589A3 Shaped body comprising an amphiphilic outer phase and a lipophilic inner phase |
| 04/11/2002 | WO2000041671A9 Composition, device, and method for subcutaneous fat removal |
| 04/11/2002 | US20020042597 Infusion system for creating microenvironments in a living body |
| 04/11/2002 | US20020042587 Polymeric foam reservoirs for an electrotransport delivery device |
| 04/11/2002 | US20020042466 Water-soluble or water-dispersible (co) polymers of hydroxyalkyl (meth) acrylates, a process for their preparation, and their use as coating agent, binder and/or film-forming excipient in pharmaceutical dosage forms |
| 04/11/2002 | US20020042453 Mixture containing surfactant |
| 04/11/2002 | US20020042448 Thickener-rheology modifier system for personal care compositions |
| 04/11/2002 | US20020042434 Pharmaceutical composition |
| 04/11/2002 | US20020042433 For promoting animal growth and improving feed utilization efficiency by an animal, and as antimicrobial component in animal feeds |
| 04/11/2002 | US20020042404 Use for budesonide and formoterol |
| 04/11/2002 | US20020042403 Use of vitamin D analogs to treat conditions related to increased oxidative stress |
| 04/11/2002 | US20020042393 Excipient |
| 04/11/2002 | US20020042388 Gene therapy for liver, lungs, tissues; determination, calibration of solution turbidity |
| 04/11/2002 | US20020042384 Integrin-targeting vectors having transfection activity |
| 04/11/2002 | US20020042378 Drug delivery; biocompatible polymer |
| 04/11/2002 | US20020042086 Activating vascular system propagation; for use in the treatment of repefusion injury and bronci defects |
| 04/11/2002 | US20020042065 Apparatus for the measurement of preferential particle in bodily fluid |
| 04/11/2002 | US20020041934 Contains separate nozzles for polymer and plasticizer dispersion without using organic solvent and without causing clogging |
| 04/11/2002 | US20020041925 Apparatus and method for coating a material |
| 04/11/2002 | US20020041907 Therapy for both intrinsic and extrinsic aging |
| 04/11/2002 | US20020041898 Novel targeted delivery systems for bioactive agents |
| 04/11/2002 | US20020041897 In biocompatible polymer |
| 04/11/2002 | US20020041896 Porous paclitaxel matrices and methods of manufacture thereof |
| 04/11/2002 | US20020041895 Controlling particle size; foring liposomes, freeze drying, rehydration |
| 04/11/2002 | US20020041894 Method of forcing the reverse transport of cholesterol from a body part to the liver while avoiding harmful disruptions of hepatic cholesterol homeostasis and pharmaceutical compositions and kit related thereto |
| 04/11/2002 | US20020041893 Biodegradable polymer and drug complex; sustained release |
| 04/11/2002 | US20020041888 Suspension containing microspheres; apoptosis inducing compound |
| 04/11/2002 | US20020041884 Adenovirus formulations |
| 04/11/2002 | US20020041879 Using synthetic or genetic engineered antigens; embedded in biopolymer |
| 04/11/2002 | US20020041867 Microencapsulated dna for vaccination and gene therapy |
| 04/11/2002 | US20020041861 Drug delivery |
| 04/11/2002 | US20020041859 Antiseptic compositions for inactivating prions |
| 04/11/2002 | DE10049297A1 Wasserlösliche oder wasserdispergierbare (Co-)Polymerisate von Hydroxyalkyl(meth)acrylaten, Verfahren zu deren Herstellung sowie deren Verwendung als Überzugs-, Bindemittel und/oder filmbildender Hilfsstoff in pharmazeutischen Darreichungsformen Water-soluble or water-dispersible (co) polymers of hydroxyalkyl (meth) acrylates, processes for their preparation and their use as coating agent, binder and / or film-forming excipient in pharmaceutical presentations |
| 04/11/2002 | DE10049225A1 Dermal therapeutic system comprises diclofenac sodium in an acrylate copolymer matrix on a polyester web |
| 04/11/2002 | DE10048888A1 Stable, film-forming aqueous polyvinyl acetate emulsion, obtained by radical polymerization in presence of regulator, useful e.g. for producing sprayable plasters or release-controlling coatings on drugs or agrochemicals |
| 04/11/2002 | DE10048840A1 Verwendung von Lipopeptiden oder Lipoproteinen zur Behandlung von Lungeninfektionen und -tumoren Use of lipopeptides or lipoproteins in the treatment of lung infections and tumors |
| 04/11/2002 | DE10047278A1 Gelling and thickening agent useful in foods, animal feeds and pharmaceutical and cosmetic products comprises Cassia tora galactomannan |
| 04/11/2002 | CA2641575A1 Stabilization of solid thyroid drug formulations |
| 04/11/2002 | CA2641570A1 Stabilization of solid thyroid drug formulations |
| 04/11/2002 | CA2427842A1 Split enveloped virus preparation for intranasal delivery |
| 04/11/2002 | CA2425906A1 Colloidal suspension of submicronic particles for carrying active principles and their mode of preparation |
| 04/11/2002 | CA2425092A1 Regulation of cell proliferation and differentiation using topically applied nucleic acid molecules |
| 04/11/2002 | CA2424981A1 Colloidal suspension of submicronic particles for carrying hydrophilic active principles (insulin) and method for preparing same |
| 04/11/2002 | CA2424936A1 Vaccine composition comprising an immunologically active substance embedded in microparticles consisting of starch with reduced molecular weight |
| 04/11/2002 | CA2424931A1 Starch |
| 04/11/2002 | CA2424896A1 A controlled-release, parenterally administrable microparticle preparation |
| 04/11/2002 | CA2424892A1 Biodegradable microparticles for controlled release administration, with purified amylopectin-based starch of reduced molecular weight |
| 04/11/2002 | CA2424888A1 Pharmaceutically acceptable starch |
| 04/11/2002 | CA2424880A1 Compositions and methods for lowering plasma lipoprotein(a) and risk factors of cardiovascular diseases |
| 04/11/2002 | CA2424863A1 Vaccine composition and stabilisation method |
| 04/11/2002 | CA2424623A1 Treatment of juvenile rheumatioid arthritis by oral administration of pooled human immunoglobulin and an antacid |
| 04/11/2002 | CA2424621A1 Combination particles for the treatment of asthma |
| 04/11/2002 | CA2424620A1 Inhalation particles incorporating a combination of two or more active ingredients |
| 04/11/2002 | CA2424607A1 Use of probiotic lactic acid bacteria for balancing the skin's immune system |
| 04/11/2002 | CA2424285A1 Use of lipopeptides or lipoproteins for the treatment of lung infections and lung tumours |
| 04/11/2002 | CA2423610A1 Split enveloped virus preparation |
| 04/11/2002 | CA2423558A1 Delivery system for multi-pharmaceutical active materials at various release rates |
| 04/11/2002 | CA2423431A1 Devices and methods for management of inflammation |
| 04/10/2002 | EP1195394A1 (Co-)Polymers of hydroxyalkyl(meth)acrylates, process for their preparation and their use in pharmaceutical dosage forms |
| 04/10/2002 | EP1195160A1 Sustained release trimetazidine pharmaceutical compositions and a method of their preparation |
| 04/10/2002 | EP1195158A1 Sprayable pharmaceutical compositions and device |
| 04/10/2002 | EP1195157A2 Make-up composition |
| 04/10/2002 | EP1194581A2 Respiratory syncytial viruses expressing immune modulatory molecules |
| 04/10/2002 | EP1194555A1 Methods for making apo-2 ligand using divalent metal ions |
| 04/10/2002 | EP1194529A1 Composition for the preservation of infectious recombinant adenoviruses |
| 04/10/2002 | EP1194525A2 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions |
| 04/10/2002 | EP1194452A1 Process for making cellulose ethers having reduced yellowing and discoloration |
| 04/10/2002 | EP1194430A1 Novel process |
| 04/10/2002 | EP1194173A1 X-ray guided drug delivery |
| 04/10/2002 | EP1194170A1 Growth hormone formulations |
| 04/10/2002 | EP1194168A2 Methods and products for manipulating uncoupling protein expression |
| 04/10/2002 | EP1194166A2 Aqueous immunologic adjuvant compositions of monophosphoryl lipid a |
| 04/10/2002 | EP1194161A1 Stable factor viii compositions |
| 04/10/2002 | EP1194154A1 Use of propionic bacteria for producing propionic acid and/or propionates in the colon |
| 04/10/2002 | EP1194153A1 Taste masked pharmaceutical liquid formulations |
| 04/10/2002 | EP1194145A2 Stable xylometazoline and oxymetazoline solution |